Search Entities About Settings

/to search

Additional Considerations — Epstein Files

Additional Considerations

Organization2 total mentions2 documentsExplore network →

Frequently mentioned alongside

2

2

2

CMC Data ComparativeOrg

2

glucagon • AllPerson

2

Global Insulin OpportunityPerson

2

United StatesPlace

2

2

Preclinical DATAOrg

2

Immunogenicity Data ComparativeOrg

2

• AdvancedOrg

2

THE EXPRESS UNDERSTANDINGOrg

2

Generic Insulin IPPerson

2

the Securities Exchange ActOrg

2

2

Clinical TrialsOrg

2

2

Bioassay Data OnePerson

2

2

Glucagon Manufacturing IPOrg

2

Explore network →

Documents mentioning “Additional Considerations”

EFTA00753599Set 9

EFTA00596368Set 9